Recruiting Prostate Cancer Studies in Hartford
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
The purpose of this post-marketing study is to further characterize the long-term outcome of known or potential risks of lutetium (177Lu) vipivotide tetraxetan also known as \[177Lu\]Lu-PSMA-617 or 17...
A Study on the Effects of Exercise Therapy on Signs of Prostate Cancer
The purpose of this study is to find out the effects of exercise therapy on indicators of prostate cancer in people with low-risk prostate cancer who are on active surveillance. The exercise therapy i...
About Prostate Cancer Clinical Trials in Hartford
Prostate cancer develops in the prostate gland and is one of the most common cancers in men. Many prostate cancers grow slowly, but some can be aggressive. Treatment options range from active surveillance to surgery, radiation, and hormone therapy.
There are currently 2 prostate cancer clinical trials recruiting participants in Hartford, CT. These studies are seeking a combined 802 participants. Research is being sponsored by Novartis Pharmaceuticals, Memorial Sloan Kettering Cancer Center. Clinical trial participation is free and participants receive study-related medical care at no cost.
Prostate Cancer Clinical Trials in Hartford — FAQ
Are there prostate cancer clinical trials in Hartford?
Yes, there are 2 prostate cancer clinical trials currently recruiting in Hartford, CT. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Hartford?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Hartford research site will contact you about next steps.
Are clinical trials in Hartford free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Hartford studies also compensate for your time and travel.
What prostate cancer treatments are being tested?
The 2 active trials in Hartford are testing new therapies including novel drugs, biologics, and treatment approaches for prostate cancer.
Data updated March 2, 2026 from ClinicalTrials.gov